Teva Pharmaceutical Industries (TEVA) Treasury Shares (2009 - 2026)

Teva Pharmaceutical Industries (TEVA) has reported Treasury Shares for 18 consecutive years, with $4.1 billion the latest figure, recorded in Q1 2026.

• Quarterly Treasury Shares changed 0.0% year-over-year to $4.1 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.1 billion (changed 0.0% YoY) and the FY2025 annual result came in at $4.1 billion, changed 0.0% from the prior year.
• Treasury Shares held at $4.1 billion in Q1 2026 per TEVA's latest filing, from $4.1 billion in the prior quarter.
• Over the last five years, Treasury Shares for TEVA reached as high as $107.0 million in Q4 2024 and fell as low as $32.3 million in Q4 2022.
• A 5-year average of $97.7 million and a median of $106.0 million in 2022 frame the typical range for Treasury Shares.
• The largest YoY upside for Treasury Shares was 0.0% in 2022 against a maximum downside of 0.0% in 2022.
• Year by year, Treasury Shares stood at $4.1 billion in 2022, then changed by 0.0% to $4.1 billion in 2023, then changed by 0.0% to $4.1 billion in 2024, then changed by 0.0% to $4.1 billion in 2025, then changed by 0.0% to $4.1 billion in 2026.
• According to Business Quant data, Treasury Shares over the past three periods registered $4.1 billion, $4.1 billion, and $4.1 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.